| Delineating copy number and clonal substructure in human tumors from single-cell transcriptomes R Gao, S Bai, YC Henderson, Y Lin, A Schalck, Y Yan, T Kumar, M Hu, ... Nature biotechnology 39 (5), 599-608, 2021 | 392 | 2021 |
| Advancing cancer research and medicine with single-cell genomics B Lim, Y Lin, N Navin Cancer cell 37 (4), 456-470, 2020 | 221 | 2020 |
| Reprogramming of lipid metabolism in cancer-associated fibroblasts potentiates migration of colorectal cancer cells J Gong, Y Lin, H Zhang, C Liu, Z Cheng, X Yang, J Zhang, Y Xiao, N Sang, ... Cell death & disease 11 (4), 267, 2020 | 152 | 2020 |
| Telomere dysfunction activates YAP1 to drive tissue inflammation D Chakravarti, B Hu, X Mao, A Rashid, J Li, J Li, W Liao, EM Whitley, ... Nature communications 11 (1), 4766, 2020 | 63 | 2020 |
| Cytoplasmic SHMT2 drives the progression and metastasis of colorectal cancer by inhibiting β-catenin degradation C Liu, L Wang, X Liu, Y Tan, L Tao, Y Xiao, P Deng, H Wang, Q Deng, ... Theranostics 11 (6), 2966, 2021 | 41 | 2021 |
| ZY0511, a novel, potent and selective LSD1 inhibitor, exhibits anticancer activity against solid tumors via the DDIT4/mTOR pathway Y Li, L Tao, Z Zuo, Y Zhou, X Qian, Y Lin, H Jie, C Liu, Z Li, H Zhang, ... Cancer letters 454, 179-190, 2019 | 38 | 2019 |
| Circadian regulator CLOCK promotes tumor angiogenesis in glioblastoma L Pang, M Dunterman, W Xuan, A Gonzalez, Y Lin, WH Hsu, F Khan, ... Cell reports 42 (2), 2023 | 28 | 2023 |
| Cocaine modifies brain lipidome in mice Y Lin, H Gu, L Jiang, W Xu, C Liu, Y Li, X Qian, D Li, Z Li, J Hu, H Zhang, ... Molecular and Cellular Neuroscience 85, 29-44, 2017 | 24 | 2017 |
| Remodeling of brain lipidome in methamphetamine-sensitized mice L Jiang, H Gu, Y Lin, W Xu, R Zhu, J Kong, L Luo, H Long, B Liu, B Chen, ... Toxicology Letters 279, 67-76, 2017 | 21 | 2017 |
| LC‑MS/MS metabolome analysis detects the changes in the lipid metabolic profiles of dMMR and pMMR cells W Peng, S Tan, Y Xu, L Wang, D Qiu, C Cheng, Y Lin, C Liu, Z Li, Y Li, ... Oncology reports 40 (2), 1026-1034, 2018 | 19 | 2018 |
| Integrative clinical and genomic characterization of MTAP-deficient metastatic urothelial cancer O Alhalabi, Y Zhu, A Hamza, W Qiao, Y Lin, RM Wang, AY Shah, ... European urology oncology 6 (2), 228-232, 2023 | 18 | 2023 |
| Oncogenic KRAS drives lipofibrogenesis to promote angiogenesis and colon cancer progression WH Hsu, KA LaBella, Y Lin, P Xu, R Lee, CE Hsieh, L Yang, A Zhou, ... Cancer discovery 13 (12), 2652-2673, 2023 | 14 | 2023 |
| 1H-NMR-based metabolic profiling of a colorectal cancer CT-26 lung metastasis model in mice Y Li, C Wang, D Li, P Deng, X Shao, J Hu, C Liu, H Jie, Y Lin, Z Li, X Qian, ... Oncology Reports 38 (5), 3044-3054, 2017 | 14 | 2017 |
| The unique pancreatic stellate cell gene expression signatures are associated with the progression from acute to chronic pancreatitis C Hu, L Yin, Z Chen, RT Waldron, A Lugea, Y Lin, X Zhai, L Wen, YP Han, ... Computational and Structural Biotechnology Journal 19, 6375-6385, 2021 | 8 | 2021 |
| Lipidomic profiling reveals lipid regulation by a novel LSD1 inhibitor treatment Y Li, X Qian, Y Lin, L Tao, Z Zuo, H Zhang, S Yang, X Cen, Y Zhao Oncology Reports 46 (5), 1-15, 2021 | 5 | 2021 |
| Lactate dehydrogenase A regulates tumor-macrophage symbiosis to promote glioblastoma progression F Khan, Y Lin, H Ali, L Pang, M Dunterman, WH Hsu, K Frenis, ... Nature communications 15 (1), 1987, 2024 | 4 | 2024 |
| Ferroptosis in cancer immunity and immunotherapy: Multifaceted interplay and clinical implications X Zhai, Y Lin, L Zhu, Y Wang, J Zhang, J Liu, L Li, X Lu Cytokine & growth factor reviews, 2023 | 4 | 2023 |
| Peroxisome proliferator‐activated receptors as therapeutic target for cancer Y Wang, F Lei, Y Lin, Y Han, L Yang, H Tan Journal of Cellular and Molecular Medicine 28 (5), e17931, 2024 | 3 | 2024 |
| Gas6/AXL pathway: immunological landscape and therapeutic potential X Zhai, D Pu, R Wang, J Zhang, Y Lin, Y Wang, N Zhai, X Peng, Q Zhou, ... Frontiers in Oncology 13, 1121130, 2023 | 3 | 2023 |
| Identification of immune subtypes of lung squamous cell carcinoma by integrative genome-scale analysis L Yin, W Zhang, D Pu, X Zhai, Y Lin, Q Wu, T Chang, J Hu, Y Li, Q Zhou Frontiers in oncology 11, 778549, 2022 | 2 | 2022 |
Nicholas NavinMD Anderson Cancer Center在 mdanderson.org 的电子邮件经过验证
Nicholas NavinMD Anderson Cancer Center在 mdanderson.org 的电子邮件经过验证